The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
15-Jan-25
Pending
$390 million
Target:
Techpoint
Acquiror:
ASMedia
Advising Techpoint (TSE: 6697), a leading fabless semiconductor company developing high-definition video connectivity technology targeting automotive and security systems, on its $390M sale to ASMedia (TWSE: 5269), a fabless semiconductor company specializing in highspeed transmission interface IC design
14-Jan-25
Pending
$166.5 million (AUD value)
Target:
Bullabulling Gold Project
Acquiror:
Minerals 260
Advising Minerals 260 on its purchase of the Bullabulling Gold Project from Norton Gold Fields (a wholly-owned subsidiary of one of the world’s largest gold producers, Zijin Mining Group)
10-Jan-25
Undisclosed
Target:
Ranger Design
Acquiror:
Clarience Technologies
Advised Ranger Design on its sale to Clarience Technologies, a portfolio company of Genstar Capital
08-Jan-25
$160 million
Target:
EMG Medallion Delaware Crude
Acquiror:
Plains All American (NASDAQ: PAA)
Advising The Energy & Minerals Group on its Sale of Delaware Basin Crude Assets to Plains All American, a publicly traded master limited partnership which operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids and natural gas
24-Dec-24
Undisclosed
Target:
Ex-US rights to branded narcolepsy treatments, Provigil® (modafinil) and Nuvigil® (armodafinil)
Acquiror:
Neuraxpharm Group
Advised Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company, on the acquisition of the ex-US rights to Provigil® (modafinil) and Nuvigil® (armodafinil) from Teva Pharmaceuticals Industries Ltd. (“Teva”)